Diamonds and Dogs


Pent up demand for sneakers. Foot Locker (FL) is up 9% as the company preannounces upside guidance. The company now expects to make 60 cents verse estimates of a loss of 60 cents. Same-store sales for the quarter have risen 18%, compared with consensus for a decline of 23.6%. Management said they have seen strong customer demand as they reopen stores. Not bad.

No love for Gilead Sciences (GILD). The drug maker is down a percent to a five-month low even as their drug, remdesivir continues to help patients with the coronavirus. Last week, Gilead inked a deal with Pfizer to manufacturing more remdesivir. Today Gilead submitted a New Drug Application to the FDA for their drug Veklury to be used with remdesivir to treatment patients with COVID-19.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.